John Rondoni - Feb 29, 2024 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Signature
/s/ Bryan Phillips, Attorney-in-Fact for John Rondoni
Stock symbol
INSP
Transactions as of
Feb 29, 2024
Transactions value $
-$1,542,441
Form type
4
Date filed
3/4/2024, 06:21 PM
Previous filing
Feb 16, 2024
Next filing
Mar 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Sale -$1.11M -6.22K -25.63% $179.23 18K Feb 29, 2024 Direct F1
transaction INSP Common Stock Sale -$14.4K -80 -0.44% $179.98 18K Feb 29, 2024 Direct F2
transaction INSP Common Stock Sale -$9.36K -52 -0.29% $179.98 17.9K Feb 29, 2024 Direct F2
transaction INSP Common Stock Sale -$404K -2.26K -12.59% $179.26 15.7K Feb 29, 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.17 to $180.25. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.11 to $180.01. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.17 to $180.14. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

All transactions reported herein were made pursuant to a Rule 10b5-1 trading plan dated November 30, 2023.